Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Platinum-resistant Recurrent Ovarian Cancer
Related studies linked through entity extraction aliases.
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
- Status
- RECRUITING
- Phase
- PHASE1
A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)
- Status
- UNKNOWN
- Phase
- PHASE2
NR in Chemo-induced Peripheral Neuropathy
- Status
- TERMINATED
- Phase
- PHASE2